SCHEMBL7634346

SCHEMBL7634346

COC(=O)c1cc(N)c(C)[nH]1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.55
XDH P47989 2/20 0.49
MAPT P10636 4/20 0.43
KDM4E B2RXH2 6/20 0.42
MAPK1 P28482 1/20 0.42
ULK1 O75385 1/20 0.41
GAA P10253 5/20 0.41
ALDH1A1 P00352 4/20 0.41
GLA P06280 3/20 0.41
HSD17B10 Q99714 3/20 0.41
HPGD P15428 2/20 0.41
CASP1 P29466 1/20 0.41
CASP7 P55210 1/20 0.41
ATM Q13315 1/20 0.41
CFTR P13569 1/20 0.40
ABL1 P00519 1/20 0.40
ALOX15 P16050 1/20 0.39
TSHR P16473 1/20 0.39
ALPL P05186 1/20 0.38
POLB P06746 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7485321 0.98 CYP1A2 (0.53) CYP1A2XDHMAPTKDM4EMAPK1
SCHEMBL13330085 0.81 ALDH1A1 (0.50) CYP1A2MAPTKDM4EGAAALDH1A1
SCHEMBL6802319 0.80 CYP1A2 (0.53) CYP1A2XDHMAPTKDM4EMAPK1
SCHEMBL20645712 0.77 CYP1A2 (0.50) CYP1A2XDHMAPTKDM4EMAPK1
SCHEMBL17130065 0.77 XDH (0.57) CYP1A2XDHMAPTKDM4EMAPK1
SCHEMBL20159041 0.74 CYP1A2 (0.47) CYP1A2XDHMAPTKDM4EMAPK1
SCHEMBL16416120 0.73 CYP1A2 (0.46) CYP1A2XDHMAPTKDM4EMAPK1
SCHEMBL9918749 0.72 CYP1A2 (0.49) CYP1A2XDHMAPTKDM4EMAPK1
SCHEMBL15865616 0.71 CYP1A2 (0.62) CYP1A2XDHMAPTKDM4EMAPK1
SCHEMBL28618724 0.71 CYP1A2 (0.52) CYP1A2XDHMAPTKDM4EMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1173223-A2 CONJUGATES AS THERAPIES FOR CANCERS AND PROSTATE DISEASES Slil Biomedical Corporation (US) 2002-01-23 EP disclosed
WO-2000066175-A2 CONJUGATES AS THERAPIES FOR CANCER AND PROSTATE DISEASES SLIL BIOMEDICAL CORPORATION (US) 2000-11-09 WO disclosed